Early research (Phase 1)Active Not RecruitingNCT06379217
What this trial is testing
NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer.
Who this might be right for
Metastatic Neuroendocrine Prostate Cancer
Novartis Pharmaceuticals 28